Skip to main content
Log in

Prevention of cocaine-induced hyperactivity by a naloxone isomer with no opiate antagonist activity

  • Original Articles
  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

Dextro-naloxone [(+)-naloxone], an isomer with almost no opiate antagonist activity and no effect on spontaneous locomotor activity, can reduce cocaine-induced hyperactivity in mice. The classical opiate antagonist,levo-naloxone [(−)-naloxone], is known to counteract the excitatory motor effects of amphetamine and cocaine, but it has been tacitly assumed that this action oflevo-naloxone is dependent on its ability to antagonize endogenous opioids. Our finding that a naloxone isomer with little or no opioid antagonist activity is also able to inhibit the cocaine effect on spontaneous motility, calls for a reconsideration of this assumption.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Alexander, G.J., and Chatterjie, N. 1991. Spontaneous motility in SW mice: amphetamine/naloxone antagonism. FASEB J. 5:A862.

    Google Scholar 

  2. Chatterjie, N., and Alexander, G.J. 1983. Naloxone-6-spiro-hydantoin: a new non-toxic compound with anticonvulsive properties. Neuropharmacol. 22:1151–1153.

    Article  CAS  Google Scholar 

  3. Chatterjie, N., Laorden, M.L., Puig, M.M., and Alexander, G.J. 1989. Prevention of hyperthermia-induced seizures in immature rats by a hydantoin derivative of naloxone. Life Sci. 45:857–862.

    Article  PubMed  CAS  Google Scholar 

  4. Hooks, M.S., Jones, D.N., Justice, J.B., and Holtzman, S.G. 1992. Naloxone reduces amphetamine-induced stimulation of locomotor activity and in vivo dopamine release in the striatum and nucleus accumbens. Pharmacol. Biochem. Behav. 41:449–453.

    Article  Google Scholar 

  5. Jones, D.N., and Holtzman, S.G. 1992. Effects of naloxone infusion upon spontaneous and apetamine-induced activity. Eur. J. Pharmacol. 221:161–165.

    Article  PubMed  CAS  Google Scholar 

  6. Jones, D.N., and Holtzman, S.G. 1994. Influence of naloxone upon motor activity induced by psychomotor stimulant drugs. Psychopharmacol. 114:215–225.

    Article  CAS  Google Scholar 

  7. Chatterjie, N., Alexander, G.J., Sechzer, J.A., and Lieberman K.W. 1995. Amphetamine/naloxone interaction: Prolonged protection by naloxyl-6α-spirohydantoin. FASEB J. 9:A1372.

    Google Scholar 

  8. Iijima, I., Minamikawa, J., Jacobson, A.E., Brossi, A., and Rice, K.C. 1978. Studies in the (+)-morphinan series. 5. Synthesis and biological properties of (+)-naloxone. J. Med. Chem. 21:398–400.

    Article  PubMed  CAS  Google Scholar 

  9. Alexander, G.J., and Chatterjie, N. 1991. (+)-Naloxone antagonizes amphetamine-induced increase in spontaneous motility. FASEB J. 5:A682.

    Google Scholar 

  10. Chatterjie, N., and Alexander, G.J. 1992. Non-opiate effects of naloxone: antagonism of amphetamine-enhanced spontaneous activity in SW mice. FASEB J. 6:A994.

    Google Scholar 

  11. Scalzo, F.M., Ali, S.F., Frambes, N.A., and Spear, L.P. 1990. Weanling rats exposed prenatally to cocaine exhibit an increase in striatal D2 dopamine binding associated with an increase in ligand affinity. Pharmacol. Biochem. Behav. 37:371–373.

    Article  PubMed  CAS  Google Scholar 

  12. Houdi, A.A., Bardo, M.T., and van Loon, G.R. 1989. Opioid mediation of cocaine-induced hyperactivity and reinforcement. Brain Res. 497:195–198.

    Article  PubMed  CAS  Google Scholar 

  13. Kosten, T.A., Kleber, H.D., and Morgan, C. 1989. Role of opioid antagonists in treating intravenous cocaine abusers. Life Sci. 44: 887–892.

    Article  PubMed  CAS  Google Scholar 

  14. Kosten, T.A. 1990. Cocaine attenuates severity of naloxone-precipitated opioid withdrawal. Life Sci. 47:1617–1623.

    Article  PubMed  CAS  Google Scholar 

  15. Ramsey, N.F., and van Ree, J.M. 1991. Intracerebroventricular naltrexone treatment attenuates acquisition of intravenous cocaine self-administration in rats. Pharmacol. Biochem. Behav. 40:807–810.

    Article  PubMed  CAS  Google Scholar 

  16. Bain, G., and Kornetsky, C. 1987. Naloxone attenuation of the effect of cocaine on rewarding brain stimulation. Life Sci. 40: 1119–1125.

    Article  PubMed  CAS  Google Scholar 

  17. Bilsky, E.J., Montegut, M.J., Delong, C.L., and Reid, L.D. 1992. Opioidergic modulation of cocaine conditioned place preference. Life Sci. 50:85–90.

    Article  Google Scholar 

  18. Brasch, H. 1986. Influence of the optical isomers of (+)- and (−)-naloxone on beating frequency, contractile force and action potentials of guinea pig isolated cardiac preparation. Brit. J. Pharmacol. 88:733–740.

    CAS  Google Scholar 

  19. Sarne, T., Hochman, I., Eshed, M., and Oppenheimer, E. 1988. Anti-arrhythmic action of naloxone: direct effect on the rat heart. Life Sci. 43:859–864.

    Article  PubMed  CAS  Google Scholar 

  20. Cregler, L.L., and Mark, H. 1986. Special report: Medical complications of cocaine abuse. New Engl. J. Med. 303:1495–1500.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chatterjie, N., Alexander, G.J., Sechzer, J.A. et al. Prevention of cocaine-induced hyperactivity by a naloxone isomer with no opiate antagonist activity. Neurochem Res 21, 691–693 (1996). https://doi.org/10.1007/BF02527726

Download citation

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02527726

Key Words

Navigation